Literature DB >> 15574571

Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.

Robert Zivadinov1, Attilio Grop, Jitendra Sharma, Alessio Bratina, Christopher W Tjoa, Michael Dwyer, Marino Zorzon.   

Abstract

BACKGROUND AND
PURPOSE: Whole-brain atrophy is of growing interest as an outcome measure in multiple sclerosis (MS) clinical trials. The authors compared the reproducibility and accuracy of 3 quantitative techniques of measurement in patients with MS.
METHODS: Thirty-four patients with relapsing-remitting MS (median Expanded Disability Status Scale disability score = 1.5) were studied. Brain parenchymal fraction (BPF) was quantified on spin-echo 2-dimensional T1-weighted axial 5-mm slice thickness sequences by semiautomated (Buffalo, Trieste) or automated (SIENAX) algorithms.
RESULTS: Mean +/- SD BPFs were 0.830 +/- 0.04 with Buffalo, 0.824 +/- 0.04 with Trieste, and 0.826 +/- 0.04 with SIENAX methods (P = nonsignificant [NS]). Mean BPF scan-rescan coefficient of variation (COV) was 0.41% for Buffalo, 0.44% for Trieste, and 0.32% for SIENAX (P =NS).The semiautomated methods showed higher accuracy than the automated method in brain extraction (masking; P = .001). The errors of skull stripping included scalp, skull bone marrow, inferior parts of temporal lobes anterior to the brain stem, face structures, sagittal sinuses, eyes, and optic nerves. Buffalo (r = -0.37, P = .034) and Trieste (r = -.36, P = .039) BPFs showed stronger cor relation with disability than SIENAX (r = -0.16, P = .219). These differences were statistically significant (P = .0031 for Buffalo and P = .0037 for Trieste BPF).
CONCLUSIONS: This study showed a high reproducibility of both semiautomated and automated methods for brain atrophy measurement. The semiautomated methods showed higher accuracy than the automated SIENAX method did in the evaluation of brain extraction, especially in infratentorial and cortical regions, where operator interaction during the masking processes was essential.

Entities:  

Mesh:

Year:  2005        PMID: 15574571     DOI: 10.1177/1051228404271010

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  9 in total

Review 1.  Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.

Authors:  Angela Vidal-Jordana; Jaume Sastre-Garriga; Alex Rovira; Xavier Montalban
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Authors:  Kerstin Bendfeldt; Bernd Taschler; Laura Gaetano; Philip Madoerin; Pascal Kuster; Nicole Mueller-Lenke; Michael Amann; Hugo Vrenken; Viktor Wottschel; Frederik Barkhof; Stefan Borgwardt; Stefan Klöppel; Eva-Maria Wicklein; Ludwig Kappos; Gilles Edan; Mark S Freedman; Xavier Montalbán; Hans-Peter Hartung; Christoph Pohl; Rupert Sandbrink; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Thomas E Nichols
Journal:  Brain Imaging Behav       Date:  2019-10       Impact factor: 3.978

3.  Automated determination of brain parenchymal fraction in multiple sclerosis.

Authors:  M Vågberg; T Lindqvist; K Ambarki; J B M Warntjes; P Sundström; R Birgander; A Svenningsson
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

4.  Cross-validation of brain segmentation by SPM5 and SIENAX.

Authors:  Hedok Lee; Isak Prohovnik
Journal:  Psychiatry Res       Date:  2008-10-18       Impact factor: 3.222

5.  A whole-brain analysis in de novo Parkinson disease.

Authors:  C Tessa; M Giannelli; R Della Nave; C Lucetti; C Berti; A Ginestroni; U Bonuccelli; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

Review 6.  Clinical correlates of grey matter pathology in multiple sclerosis.

Authors:  Dana Horakova; Tomas Kalincik; Jana Blahova Dusankova; Ondrej Dolezal
Journal:  BMC Neurol       Date:  2012-03-07       Impact factor: 2.474

7.  Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.

Authors:  C Wang; H N Beadnall; S N Hatton; G Bader; D Tomic; D G Silva; M H Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-04-12       Impact factor: 10.154

8.  The neuroimaging magnitude of pediatric brain atrophy in northern Tanzania.

Authors:  Richard Erasto Sungura; John Martin Spitsbergen; Emmanuel Abraham Mpolya; Elingarami Sauli; John-Mary Vianney
Journal:  Pan Afr Med J       Date:  2020-05-21

9.  Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.

Authors:  Christopher C Hemond; Renxin Chu; Subhash Tummala; Shahamat Tauhid; Brian C Healy; Rohit Bakshi
Journal:  Brain Behav       Date:  2018-07-18       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.